Enhabit, Inc. (NYSE:EHAB) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Enhabit, Inc. (NYSE:EHAB) have received an average recommendation of “Hold” from the nine brokerages that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $13.5714.

Several analysts have issued reports on the company. Weiss Ratings restated a “sell (e+)” rating on shares of Enhabit in a report on Monday, December 29th. Deutsche Bank Aktiengesellschaft raised shares of Enhabit to a “buy” rating in a research report on Tuesday, January 13th. Truist Financial set a $13.80 price target on shares of Enhabit in a report on Monday, February 23rd. UBS Group restated a “neutral” rating and issued a $13.80 price target (up from $12.00) on shares of Enhabit in a research report on Tuesday, February 24th. Finally, Oppenheimer lowered shares of Enhabit from an “outperform” rating to a “market perform” rating in a research note on Monday, February 23rd.

Insider Activity

In other news, EVP Julie Diane Jolley sold 2,793 shares of the firm’s stock in a transaction on Monday, March 9th. The stock was sold at an average price of $13.63, for a total value of $38,068.59. Following the completion of the sale, the executive vice president owned 139,923 shares of the company’s stock, valued at $1,907,150.49. This trade represents a 1.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 3.40% of the stock is owned by insiders.

Institutional Investors Weigh In On Enhabit

Several hedge funds have recently bought and sold shares of EHAB. Osaic Holdings Inc. boosted its position in Enhabit by 337.5% during the 2nd quarter. Osaic Holdings Inc. now owns 2,616 shares of the company’s stock worth $25,000 after acquiring an additional 2,018 shares during the period. State of Alaska Department of Revenue acquired a new position in shares of Enhabit in the 3rd quarter valued at about $27,000. Tower Research Capital LLC TRC lifted its position in shares of Enhabit by 82.9% in the second quarter. Tower Research Capital LLC TRC now owns 4,542 shares of the company’s stock worth $44,000 after purchasing an additional 2,059 shares in the last quarter. Russell Investments Group Ltd. lifted its position in shares of Enhabit by 523.1% in the second quarter. Russell Investments Group Ltd. now owns 5,795 shares of the company’s stock worth $56,000 after purchasing an additional 4,865 shares in the last quarter. Finally, Simplex Trading LLC boosted its holdings in shares of Enhabit by 69.8% during the fourth quarter. Simplex Trading LLC now owns 8,115 shares of the company’s stock worth $75,000 after purchasing an additional 3,336 shares during the period.

Enhabit Stock Performance

EHAB opened at $13.66 on Friday. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.76. The firm has a market cap of $692.58 million, a PE ratio of -151.72 and a beta of 1.56. The business has a fifty day simple moving average of $12.26 and a 200-day simple moving average of $9.97. Enhabit has a fifty-two week low of $6.47 and a fifty-two week high of $13.69.

Enhabit (NYSE:EHAB) last announced its earnings results on Wednesday, March 4th. The company reported $0.14 EPS for the quarter, meeting the consensus estimate of $0.14. Enhabit had a positive return on equity of 4.71% and a negative net margin of 0.43%.The business had revenue of $270.40 million during the quarter, compared to the consensus estimate of $270.56 million. As a group, equities analysts predict that Enhabit will post 0.22 EPS for the current fiscal year.

Enhabit Company Profile

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.